Equities

TriMas Corp

TriMas Corp

Actions
  • Price (EUR)23.80
  • Today's Change0.40 / 1.71%
  • Shares traded0.00
  • 1 Year change-4.03%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 07:03 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TriMas Corporation manufactures a diverse set of products primarily for the consumer products, aerospace and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. The Company's segments include Packaging, Aerospace and Specialty Products. The Packaging segment consists of the Rieke, Affaba & Ferrari, Taplast, Rapak, Plastic Srl, Aarts Packaging, Intertech and Omega brands. The Company develops and manufactures a range of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components. The Aerospace segment is a designer and manufacturer of a diverse range of products, including highly-engineered fasteners, collars, blind bolts, rivets, ducting and connectors for air management systems. The Specialty Products segment is comprised of its Norris Cylinder and Arrow Engine Company businesses.

  • Revenue in USD (TTM)893.55m
  • Net income in USD40.36m
  • Incorporated1986
  • Employees3.40k
  • Location
    TriMas Corp39400 WOODWARD AVENUE, SUITE 130BLOOMFIELD HILLS 48304United StatesUSA
  • Phone+1 (248) 631-5400
  • Fax+1 (248) 382-1496
  • Websitehttps://www.trimascorp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.